463 related articles for article (PubMed ID: 2822825)
1. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
[TBL] [Abstract][Full Text] [Related]
2. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
Kazmierowski JA; Gallin JI; Reynolds HY
J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
Desai U; Dickey B; Varani J; Kreutzer DL
J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
[TBL] [Abstract][Full Text] [Related]
4. [The role of chemotactic factors in the pathogenesis of sarcoid granuloma formation].
Ohdama S
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Mar; 28(3):457-64. PubMed ID: 2214385
[TBL] [Abstract][Full Text] [Related]
5. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
[TBL] [Abstract][Full Text] [Related]
6. The significance of complement activation in the pathogenesis of hypersensitivity pneumonitis: sequential changes of complement components and chemotactic activities in bronchoalveolar lavage fluids.
Yoshizawa Y; Nomura A; Ohdama S; Tanaka M; Morinari H; Hasegawa S
Int Arch Allergy Appl Immunol; 1988; 87(4):417-23. PubMed ID: 2852642
[TBL] [Abstract][Full Text] [Related]
7. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients.
Teran LM; Campos MG; Begishvilli BT; Schröder JM; Djukanovic R; Shute JK; Church MK; Holgate ST; Davies DE
Clin Exp Allergy; 1997 Apr; 27(4):396-405. PubMed ID: 9146932
[TBL] [Abstract][Full Text] [Related]
8. Modulation of alveolar macrophage leukotriene B4 released by complement component C5.
Robbins RA; Gossman GL; Allington LA; Kendall TJ; Stull TW; Rennard SI
J Lab Clin Med; 1990 Apr; 115(4):497-503. PubMed ID: 2157785
[TBL] [Abstract][Full Text] [Related]
9. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Martin TR; Raugi G; Merritt TL; Henderson WR
J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
[TBL] [Abstract][Full Text] [Related]
10. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
Charo IF; Yuen C; Perez HD; Goldstein IM
J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
[TBL] [Abstract][Full Text] [Related]
11. Macrophage inflammatory protein-1 alpha expression in interstitial lung disease.
Standiford TJ; Rolfe MW; Kunkel SL; Lynch JP; Burdick MD; Gilbert AR; Orringer MB; Whyte RI; Strieter RM
J Immunol; 1993 Sep; 151(5):2852-63. PubMed ID: 8360496
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil chemotactic factors in bacterial pneumonia.
Hopkins H; Stull T; Von Essen SG; Robbins RA; Rennard SI
Chest; 1989 May; 95(5):1021-7. PubMed ID: 2539955
[TBL] [Abstract][Full Text] [Related]
13. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
[TBL] [Abstract][Full Text] [Related]
14. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.
Ozaki T; Hayashi H; Tani K; Ogushi F; Yasuoka S; Ogura T
Am Rev Respir Dis; 1992 Jan; 145(1):85-91. PubMed ID: 1309969
[TBL] [Abstract][Full Text] [Related]
16. Human alveolar macrophages from smokers have an impaired capacity to secrete LTB4 but not other chemotactic factors.
Wieslander E; Linden M; Håkansson L; Eklund A; Blaschke E; Brattsand R; Venge P
Eur J Respir Dis; 1987 Oct; 71(4):263-72. PubMed ID: 2826202
[TBL] [Abstract][Full Text] [Related]
17. Human alveolar macrophages release a factor that inhibits phagocyte function.
Sibille Y; Merrill WW; Naegel GP; Care SB; Cooper JA; Reynolds HY
Am J Respir Cell Mol Biol; 1989 Nov; 1(5):407-16. PubMed ID: 2561589
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.
Hubbard RC; Fells G; Gadek J; Pacholok S; Humes J; Crystal RG
J Clin Invest; 1991 Sep; 88(3):891-7. PubMed ID: 1653278
[TBL] [Abstract][Full Text] [Related]
19. Changes in the broncho-alveolar lavage fluid in smokers and patients with chronic obstructive lung disease.
Terpstra GK; Wassink GA; Huidekoper HJ
Int J Clin Pharmacol Res; 1987; 7(5):357-61. PubMed ID: 3312045
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of inflammatory cytokine secretion by human alveolar macrophages.
Losa García JE; Rodríguez FM; Martín de Cabo MR; García Salgado MJ; Losada JP; Villarón LG; López AJ; Arellano JL
Mediators Inflamm; 1999; 8(1):43-51. PubMed ID: 10704089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
